FDA moves toward easing restrictions on certain peptides BioPharma Dive Here's your Monthly Dose my supplement spotlight on what's trending, what's promising, and what actually holds up under scientific scrutiny. This month: BPC 157. Often called the injury recovery peptide, BPC 157 has Is BPC 157 Banned? Oral vs. Injectable Forms Explained Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York